Ignacio Anglada

Ignacio Anglada is a seasoned finance professional with extensive experience in the pharmaceutical industry. Currently serving as the Group Chief Financial Officer at Taqeef since May 2025, Ignacio previously held the same title at Julphar from May 2022 to April 2025. Ignacio's expertise includes positions such as Finance Director for the Biologics Division at Lonza and Global Finance Head for various departments at Novartis, showcasing a strong background in driving performance and cross-functional leadership. Ignacio began the career as a Financial Controller at DERBI (Grupo Piaggio) and has advanced education credentials, including an Executive Finance Excellence degree from Harvard Business School and an MBA from Esade.